XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value of Financial Instruments [Abstract]  
Assets and Liabilities Measured at Fair Value on a Recurring and Nonrecurring Basis

Fair Value Measurements at

December 31, 2022 Using

(In Thousands)

    

Assets & Liabilities
Measured at

    

Quoted Prices
in Active
Markets for
Identical Assets

    

Significant
Other
Observable
Inputs

    

Significant
Unobservable
Inputs

Description

12/31/22

(Level 1)

(Level 2)

(Level 3)

Recurring:

Investment securities available-for-sale:

U.S. government agencies

$

9,462

$

9,462

Residential mortgage-backed agencies

$

37,401

$

37,401

Commercial mortgage-backed agencies

$

30,732

$

30,732

Collateralized mortgage obligations

$

21,044

$

21,044

Obligations of states and political subdivisions

$

10,492

$

10,492

Corporate bonds

$

887

$

887

Collateralized debt obligations

$

15,871

$

15,871

Financial derivative

$

1,068

$

1,068

Non-recurring:

Impaired loans

$

211

$

211

Equity investments

$

1,796

$

1,796

Other real estate owned

$

$

Fair Value Measurements at

December 31, 2021 Using

(In Thousands)

    

Assets & Liabilities
Measured at

    

Quoted Prices
in Active
Markets for
Identical Assets

    

Significant
Other
Observable
Inputs

        

Significant
Unobservable
Inputs

Description

12/31/21

(Level 1)

(Level 2)

(Level 3)

Recurring:

Investment securities available-for-sale:

U.S. government agencies

$

67,169

$

67,169

Residential mortgage-backed agencies

$

48,661

$

48,661

Commercial mortgage-backed agencies

$

50,868

$

50,868

Collateralized mortgage obligations

$

90,077

$

90,077

Obligations of states and political subdivisions

$

12,804

$

12,804

Collateralized debt obligations

$

17,192

$

17,192

Financial derivative

$

(453)

$

(453)

Non-recurring:

Impaired loans

$

408

$

408

Equity investment

$

590

$

590

Other real estate owned

$

349

$

349

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques

(in thousands)

    

Fair Value at
December 31,
2022

    

Valuation
Technique

    

Significant
Unobservable
Inputs

    

Significant
Unobservable
Input Value

Recurring:

Investment Securities – available for sale - CDO

$

15,871

Discounted Cash Flow

Discount Rate

Range of low to mid 300 and low to high 400

Non-recurring:

Impaired Loans

$

211

Market Comparable Properties

Marketability Discount

10.0% to 15.0%

Equity Investments

$

1,796

Market Method

Revenue Multiples

2.8x

Other Real Estate Owned

$

Market Comparable Properties

Marketability Discount

(in thousands)

    

Fair Value at
December 31,
2021

    

Valuation
Technique

    

Significant
Unobservable
Inputs

    

Significant
Unobservable
Input Value

Recurring:

Investment Securities –  available for sale - CDO

$

17,192

Discounted Cash Flow

Discount Rate

Libor+ 3.25%

Non-recurring:

Impaired Loans

$

408

Market Comparable Properties

Marketability Discount

10.0% to 15.0% (1)
(weighted avg 13.2%)

Equity Investment

$

590

Market Method

Revenue Multiples

2.8x

Other Real Estate Owned

$

349

Market Comparable Properties

Marketability Discount

15.0%

(1)Range would include discounts taken since appraisal and estimated values
Reconciliation of Fair Valued Assets Measured on a Recurring Basis

Fair Value
Measurements Using
Significant

Unobservable Inputs

(Level 3)

(In Thousands)

    

Investment Securities
Available for Sale

Beginning balance January 1, 2022

$

17,192

Total gains/(losses) realized/unrealized:

Included in other comprehensive income

(1,321)

Ending balance December 31, 2022

$

15,871

Fair Value
Measurements Using
Significant

Unobservable Inputs

(Level 3)

(In Thousands)

    

Investment Securities
Available for Sale

Beginning balance January 1, 2021

$

13,260

Total gains/(losses) realized/unrealized:

Included in other comprehensive loss

3,932

Ending balance December 31, 2021

$

17,192

Fair Value by Balance Sheet Grouping

December 31, 2022

Fair Value Measurements

Carrying

Fair

Quoted Prices
in Active
Markets for
Identical
Assets

Significant
Other
Observable
Inputs

Significant
Unobservable
Inputs

(in thousands)

    

Amount

    

Value

    

(Level 1)

    

(Level 2)

    

(Level 3)

Financial Assets:

Cash and due from banks

$

72,720

$

72,720

$

72,720

Interest bearing deposits in banks

1,595

1,595

1,595

Investment securities - AFS

125,889

125,889

$

110,018

$

15,871

Investment securities - HTM

235,659

203,080

182,380

20,700

Restricted bank stock

1,027

N/A

Loans, net

1,264,684

1,177,702

1,177,702

Financial derivative

1,068

1,068

1,068

Accrued interest receivable

6,051

6,051

6,051

Financial Liabilities:

Deposits – non-maturity

1,450,210

1,450,210

1,450,210

Deposits – time deposits

120,523

120,083

120,083

Short-term borrowed funds

64,565

64,565

64,565

Long-term borrowed funds

30,929

30,909

30,909

Accrued interest payable

151

151

151

Off balance sheet financial instruments

December 31, 2021

Fair Value Measurements

Carrying

Fair

Quoted Prices
in Active
Markets for
Identical
Assets

Significant
Other
Observable
Inputs

Significant
Unobservable
Inputs

(In thousands)

    

Amount

    

Value

    

(Level 1)

    

(Level 2)

    

(Level 3)

Financial Assets:

Cash and due from banks

$

109,823

$

109,823

$

109,823

Interest bearing deposits in banks

5,897

5,897

5,897

Investment securities - AFS

286,771

286,771

$

269,579

$

17,192

Investment securities - HTM

56,259

65,369

36,448

28,921

Restricted bank stock

1,029

N/A

Loans, net

1,137,440

1,122,671

1,122,671

Accrued interest receivable

4,821

4,821

4,821

Financial Liabilities:

Deposits – non-maturity

1,306,145

1,306,145

1,306,145

Deposits – time deposits

163,229

163,961

163,961

Financial derivative

453

453

453

Short-term borrowed funds

57,699

57,699

57,699

Long-term borrowed funds

30,929

31,085

31,085

Accrued interest payable

137

137

137

Off balance sheet financial instruments